A short discussion about the SARS-CoV-2 mRNA-1273 vaccine

Abstract

The COVID-19 global pandemic has prompted accelerated vaccine development efforts. This perspective discusses the importance of SARS-CoV-2 vaccine candidates’ recruitment of cellular T-cell immunity and encourages industry to increasingly investigate and publish parameters related to cellular immunity in their research reports.

Keywords

• SARS-CoV-2
• COVID-19
• Vaccine